Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PEACH SUPUPRAMAI

NPI
1235766296
CMS profile
11305093
Location
FORT LAUDERDALE, FL

General Payments · PY2021–2024

$1,258.10

  • Reported across 44 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,216.99

42 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,216.99 42

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $440.14 12
Amgen Inc. $290.03 14
Lilly USA, LLC $181.46 12
DAVOL INC. $161.85 1
Phathom Pharmaceuticals, Inc. $108.28 1
Almatica Pharma Inc. $18.93 1
Esperion Therapeutics, Inc. $16.30 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $14.36 1
PY2023 $26.75 1
PY2024 $1,216.99 42

Payment records · PY2024 (42)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20212023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Almatica Pharma LLC $18.93 10/11/2024 Food and Beverage Undisputed 01/23/2026 1137580434 CMS
Amgen Inc. $15.08 01/12/2024 Food and Beverage Undisputed 01/23/2026 1116162479 CMS
Amgen Inc. $14.82 01/26/2024 Food and Beverage Undisputed 01/23/2026 1117695701 CMS
Amgen Inc. $8.08 02/14/2024 Food and Beverage Undisputed 01/23/2026 1116162487 CMS
Amgen Inc. $14.44 03/01/2024 Food and Beverage Undisputed 01/23/2026 1117695703 CMS
Amgen Inc. $121.18 03/13/2024 Food and Beverage Undisputed 01/23/2026 1116162528 CMS
Amgen Inc. $9.53 05/08/2024 Food and Beverage Undisputed 01/23/2026 1116162493 CMS
Amgen Inc. $9.88 06/04/2024 Food and Beverage Undisputed 01/23/2026 1116162501 CMS
Amgen Inc. $20.18 06/04/2024 Food and Beverage Undisputed 01/23/2026 1116162535 CMS
Amgen Inc. $11.93 07/16/2024 Food and Beverage Undisputed 01/23/2026 1116162507 CMS
Amgen Inc. $9.66 09/12/2024 Food and Beverage Undisputed 01/23/2026 1116162542 CMS
Amgen Inc. $9.49 09/27/2024 Food and Beverage Undisputed 01/23/2026 1116162514 CMS
Amgen Inc. $6.08 10/16/2024 Food and Beverage Undisputed 01/23/2026 1116162521 CMS
Amgen Inc. $24.07 10/23/2024 Food and Beverage Undisputed 01/23/2026 1116162549 CMS
Amgen Inc. $15.61 10/25/2024 Food and Beverage Undisputed 01/23/2026 1117695705 CMS
Davol Inc. $161.85 08/15/2024 Food and Beverage Undisputed 01/23/2026 1127662709 CMS
Esperion Therapeutics, Inc. $16.30 05/03/2024 Food and Beverage Undisputed 01/23/2026 1129457026 CMS
Lilly USA, LLC $7.45 02/14/2024 Food and Beverage Undisputed 01/23/2026 1135315598 CMS
Lilly USA, LLC $99.82 04/17/2024 Food and Beverage Undisputed 01/23/2026 1135315228 CMS
Lilly USA, LLC $8.14 05/28/2024 Food and Beverage Undisputed 01/23/2026 1135280412 CMS
Lilly USA, LLC $7.04 06/26/2024 Food and Beverage Undisputed 01/23/2026 1135189501 CMS
Lilly USA, LLC $4.91 07/30/2024 Food and Beverage Undisputed 01/23/2026 1135288690 CMS
Lilly USA, LLC $8.57 08/14/2024 Food and Beverage Undisputed 01/23/2026 1135288694 CMS
Lilly USA, LLC $7.69 08/20/2024 Food and Beverage Undisputed 01/23/2026 1135288698 CMS
Lilly USA, LLC $6.99 09/05/2024 Food and Beverage Undisputed 01/23/2026 1135280416 CMS
Lilly USA, LLC $8.56 10/02/2024 Food and Beverage Undisputed 01/23/2026 1135289305 CMS
Lilly USA, LLC $6.52 10/15/2024 Food and Beverage Undisputed 01/23/2026 1135315232 CMS
Lilly USA, LLC $7.05 10/23/2024 Food and Beverage Undisputed 01/23/2026 1135280419 CMS
Lilly USA, LLC $8.72 11/12/2024 Food and Beverage Undisputed 01/23/2026 1135288702 CMS
Novo Nordisk Inc $7.84 03/06/2024 Food and Beverage Undisputed 01/23/2026 1108583417 CMS
Novo Nordisk Inc $125.00 03/07/2024 Food and Beverage Undisputed 01/23/2026 1108580465 CMS
Novo Nordisk Inc $22.16 04/09/2024 Food and Beverage Undisputed 01/23/2026 1108580133 CMS
Novo Nordisk Inc $16.79 06/05/2024 Food and Beverage Undisputed 01/23/2026 1108580663 CMS
Novo Nordisk Inc $18.30 06/26/2024 Food and Beverage Undisputed 01/23/2026 1108581325 CMS
Novo Nordisk Inc $21.37 07/19/2024 Food and Beverage Undisputed 01/23/2026 1108581059 CMS
Novo Nordisk Inc $124.99 08/21/2024 Food and Beverage Undisputed 01/23/2026 1108582837 CMS
Novo Nordisk Inc $7.62 08/22/2024 Food and Beverage Undisputed 01/23/2026 1108580799 CMS
Novo Nordisk Inc $24.27 09/10/2024 Food and Beverage Undisputed 01/23/2026 1108582289 CMS
Novo Nordisk Inc $25.00 09/23/2024 Food and Beverage Undisputed 01/23/2026 1108580295 CMS
Novo Nordisk Inc $22.50 10/17/2024 Food and Beverage Undisputed 01/23/2026 1108582629 CMS
Novo Nordisk Inc $24.30 12/10/2024 Food and Beverage Undisputed 01/23/2026 1108580517 CMS
Phathom Pharmaceuticals, Inc. $108.28 05/01/2024 Food and Beverage Undisputed 01/23/2026 1151131091 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.